期刊文献+

Risk factors for intraocular metastasis of primary liver cancer in diabetic patients:Alpha-fetoprotein and cancer antigen 125 被引量:7

下载PDF
导出
摘要 BACKGROUND In rare instances,primary liver cancer can be associated with intraocular metastasis(IOM).AIM To investigate the correlation between a diverse range of clinical characteristics and IOM in diabetic patients with primary liver cancer,and to determine potential risk factors in predicting IOM.METHODS We recruited a total of 722 diabetic patients with primary liver cancer.The differences between the IOM and non-intraocular metastasis(NIOM)groups in these patients were assessed using the chi-squared test and Student’s t-test.Binary logistic regression analysis was subsequently used to determine risk factors.Finally,the diagnostic value of IOM in this cohort with primary liver cancer was analyzed by receiver operating characteristic(ROC)curve analysis.RESULTS In all,13 patients had IOM.There were no remarkable intergroup differences with respect to age,sex,histopathological sub-types,or blood biochemical parameters.However,the IOM group had significantly higher alpha-fetoprotein(AFP)and cancer antigen 125(CA125)values than the NIOM group.Binary logistic regression identified AFP and CA125 to be significant risk factors for IOM in diabetic patients with primary liver cancer.ROC curve analysis showed that the area under the curve values for AFP and CA125 were 0.727 and 0.796,with the cut-off values of 994.20 ng/mL and 120.23 U/mL,respectively.The sensitivity and specicity for AFP were 92.3%and 59.9%,while those for CA125 were 84.6%and 70.1%,respectively.CONCLUSION Elevated AFP and CA125 represent significant risk factors for IOM in diabetic patients with primary liver cancer.
出处 《World Journal of Diabetes》 SCIE 2021年第2期158-169,共12页 世界糖尿病杂志(英文版)(电子版)
基金 Supported by The National Natural Science Foundation of China,No.81400372 and 81660158 the Key Research and Development Plan of Jiangxi Province,No.20181BBG70004 the Young Scientists Fund of Jiangxi Province,No.20161ACB21017 and 20151BAB215016 the Science and Technology Plan Project of Jiangxi Province,No.20151BBG70223 and the Distinguished Young Scientists Fund of Jiangxi Province,No.20192BCBL23020.
  • 相关文献

参考文献2

二级参考文献118

  • 1Zou, Wei-Long,Zang, Yun-Jin,Chen, Xin-Guo,Shen, Zhong-Yang.Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2008,7(2):145-151. 被引量:17
  • 2Chang Liu,Guang-Qin Xiao,Lu-Nan Yan,Bo Li,Li Jiang,Tian-Fu Wen,Wen-Tao Wang,Ming-Qing Xu,Jia-Yin Yang.Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma[J].World Journal of Gastroenterology,2013,19(11):1811-1819. 被引量:23
  • 3Hsieh MY, Chang WY, Wang LY, Chen SC, Chuang WL, Lu SN, Wu DK. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors. Cancer Chemotherapy & Pharmacology 1992; 31:S82-85.
  • 4Yoshimi F, Nagao T, Inoue S, Kawano N, Muto T, Gunji T,Ohnishi S, Imawari M. Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial. Hepatolology 1992; 16:702-706.
  • 5Bonfil RD, Bustuoabad OD, Ruggiero RA, Meiss RP, Pasqualini CD. Tumor necrosis can facilitate the appearance of metastasis.Clin Exp Metastasis 1988; 6:121-129.
  • 6Lee YT, Geer DA. Primary liver cancer: pattern of metastasis. J Surg Oncol 1987; 36:26-31.
  • 7Liou TC, Shih SC, Kao CR, Chou SY, Lin SC, Wang HY. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization. J Hepatol 1995; 23:563-568.
  • 8Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 1977;35:1-39.
  • 9Hashimoto N, Kobayashi M, Tsuji T. Serum type IV collagendegrading enzyme in hepatocellular carcinoma with metastasis.Acta Med Okatlama 1988: 42:1-6.
  • 10Isoai A, Giga-Hama Y, Shinkai K, Mukai M, Akedo H, Kumagai H. Tumor invasion-inhibiting factor 2: primary structure and inhibitory effect on invasion in vitro and pulmonary metastasis of tumor cells. Cancer Res 1992; 52:1422-1426.

共引文献20

同被引文献54

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部